With its promise to bring new insights into the diagnosis and treatment of conditions as varied as cancer, cardiovascular and neurodegenerative diseases, bioelectronic medicine is now in the spotlight. Bringing together various ...
Jan 28, 2020
0
1
Hepatocellular carcinoma (HCC) is the most common type of liver cancer. It is a major global health concern with rising rates, particularly in North Africa and East Asia. Although potentially curable in the early stages, ...
Dec 29, 2023
0
4
All of the newly diagnosed glioblastoma multiforme patients enrolled in a Phase 1 clinical trial at the University of Alabama at Birmingham have exceeded both their median and expected progression-free survivals. Two patients, ...
Jun 10, 2022
0
9
Though per- and polyfluoroalkyl substances (PFAS) make headlines daily, a new paper reveals that most studies finding links between PFAS exposure and human health harms are published without a press release and receive little ...
Jul 17, 2023
0
42
A sister-to-sister kidney transplant in France reported Wednesday is the first to combine robotics, vaginal access and the donated organ's immediate implant after removal, according to the surgeons.
Aug 19, 2015
0
208
A 33-year old man was found to have a second SARS-CoV-2 infection some four and a half months after he was diagnosed with his first, from which he recovered. The man, who showed no symptoms, was diagnosed when he returned ...
Aug 25, 2020
0
5
Moderna said Monday that a booster dose of its COVID-19 vaccine should offer protection against the rapidly spreading omicron variant.
Dec 20, 2021
0
60
On the heels of a new study from the Centers for Disease Control and Prevention showing that Zika has increased the rate of birth defects in the United States, Florida health officials on Thursday reported three more cases ...
Mar 3, 2017
0
3
Moderna's experimental COVID-19 vaccine that combines its original shot with protection against the omicron variant appears to work, the company announced Wednesday.
Jun 8, 2022
0
27
(HealthDay)—The 32-mg, single intravenous dose of Zofran (ondansetron), an anti-nausea drug, is being removed from the market due to its potential to cause serious, even fatal, cardiac damage, according to a Drug Safety ...
Dec 6, 2012
0
0
